Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. May 15, 2013; 5(5): 88-96
Published online May 15, 2013. doi: 10.4251/wjgo.v5.i5.88
Published online May 15, 2013. doi: 10.4251/wjgo.v5.i5.88
Targeted treatments for metastatic esophageal squamous cell cancer
Antonia Digklia, Ioannis A Voutsadakis, Centre Pluridisciplinaire d’Oncologie, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland
Author contributions: Digklia A performed literature search and wrote part of the manuscript; Voutsadakis IA conceived the paper, wrote parts and revised the manuscript.
Correspondence to: Ioannis A Voutsadakis, MD, PhD, Centre Pluridisciplinaire d’Oncologie, Centre Hospitalier Universitaire Vaudois, Bugnon 46, 1011 Lausanne, Switzerland. ivoutsadakis@yahoo.com
Telephone: +41-21-3145122 Fax: +41-21-2140188
Received: November 12, 2012
Revised: April 18, 2013
Accepted: May 13, 2013
Published online: May 15, 2013
Revised: April 18, 2013
Accepted: May 13, 2013
Published online: May 15, 2013
Core Tip
Core tip: This paper discusses some of these targeted agents in more advanced development in metastatic esophageal squamous cell carcinomas, as well as some promising drugs with pre-clinical or initial clinical data in the disease.